The Food and Drug Administration (FDA) has cleared the SAINT Neuromodulation System for the treatment of refractory depression in adults, ...

In the study, almost 80% of patients with treatment-resistant depression experienced remission after receiving modified transcranial magnetic stimulation.

Molecular Psychiatry - Chronometric TMS-fMRI of personalized left dorsolateral prefrontal target reveals state-dependency of subgenual anterior cingulate cortex effects

Major depressive disorder (MDD) is widely hypothesized to result from disordered communication across brain-wide networks. Yet, prior resting-state...

Translational Psychiatry - Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial

Objective: Depression is the leading cause of disability worldwide, and half of patients with depression have treatment-resistant depression. Intermittent theta-burst stimulation (iTBS) is approved...

Brain stimulation poised to move from last resort to frontline treatment

Bipolar disorder is a highly disabling illness [1]. While mania and hypomania define bipolar I and II, respectively, depression accounts for the majority of disease burden in bipolar disorder....

A new study led by Stanford Medicine researchers is the first to reveal how magnetic stimulation treats severe depression: by correcting the abnormal flow of brain signals.

Objective: Depression is the leading cause of disability worldwide, and half of patients with depression have treatment-resistant depression. Intermittent theta-burst stimulation (iTBS) is approved...

Magnus Medical announces the commercial launch of its groundbreaking SAINT® neuromodulation system for the treatment of major depression.

Doctors have put a new twist on a treatment for depression that has been around for nearly 15 years that utilizes magnets. NBC’s senior consumer investigative correspondent Vicky Nguyen reports for...

A look at the features for this week's broadcast of the #1 Sunday morning news program

How deeply someone can be hypnotized—known as hypnotizability—appears to be a stable trait that changes little throughout adulthood, much like personality and IQ. But now, for the first time,...

In this CME article, review the principles and applications of both invasive and noninvasive neuromodulation techniques for the treatment of mood disorders.

Teresa Sanchez, whose bi-polar disorder has stalked her for years, tried numerous treatments, before undergoing an experimental procedure, called SAINT (Stan...

This episode is brought to you by: Nordic Naturals, the #1-selling fish-oil and algae-oil brand in the U.S.: https://www.nordic.com/tim (20% off)Eight Sleep’...

Nature Neuroscience - Ibogaine therapy in TBI

The landscape of psychiatry is ever evolving and has recently begun to be influenced more heavily by new technologies. One novel technology which may have pa...

A novel TMS protocol is being hailed as a revolutionary treatment for patients with the severest depression. Steven M. Strakowski speaks with experts about what's next for this potential gamechanger.

After becoming paralyzed from the chest down, the mountain athlete found an unlikely ally in recovery: psychedelics

Participant and Actual Films announced an untitled documentary about the use of psychedelics to treat veterans' PTSD and brain trauma.

Stanford Medicine researchers used high doses of magnetic stimulation, delivered on an accelerated timeline and targeted to individual neurocircuitry, to treat patients with severe depression.

A newly published review charts the history of using neuromodulation to treat depression and looks at new developments in the field and possible future directions.

Nature - Two studies report considerable improvements in technologies designed to help people with facial paralysis to communicate.

The holiday season may be the most wonderful time of the year, but that is not the case for everyone. The season can present additional stress and depression, especially in the age of COVID-19. Now,...

By age 75 years, approximately half the population can expect to develop one or more of the 13 mental disorders considered in this Article. These disorders typically first emerge in childhood,...

NOTE FROM TED: Do not look to this talk for medical or mental health advice. Ibogaine has been associated with cases of fatal cardiac arrhythmia. Experiments...

Reflecting on the past year, the editors and writers of the Office of Communications picked some of the most significant scientific achievements they covered at Stanford Medicine in 2023.

Nature - ‘Jarring’ study reveals hiring bias at US institutions.

Magnus Medical announced the commercial launch of its Saint neuromodulation system for treatment-resistant major depressive disorder (MDD).

Nature Mental Health - In this pilot study, the authors detected specific brain regions that can be precisely targeted with transcranial magnetic stimulation to influence heart rate. The...

Ibogaine, illegal in the United States, is a "new" but very old treatment approach in curing opioid and other addictions, as well as improving traumatic brain injury.

Neuromodulation has been a fast-growing area of medicine for at least a decade.

A treatment for depression from Stanford helped nearly 80 percent of patients enter remission within days. The technique delivers pulses of magnetic energy to stimulate the brain. It’s not new, but...

Transcranial magnetic stimulation delivers pulses to the brain and speeds up the treatment of depression.

At Psychedelic Science 2023, more than 12,000 people gathered to discuss the potential benefits of psychedelics like MDMA, psilocybin and ketamine.

A novel, but controversial, way to combat the opioid epidemic is being debated in one of the nation’s hardest hit states: Kentucky. As officials across the U.S. look to counter addiction, many...